The Latest Cardiac and Vascular News
Arise Vascular opens Cardiovascular Surgery Center to bring high-quality, high-value, outpatient cardiovascular procedures to the area. AUSTIN, Texas, Aug. 30, 2021 /PRNewswire/ — Lafayette, Louisiana is getting its first outpatient cardiovascular surgery center, bringing a new level of convenience, cost savings and state-of-the art care to the area. That’s because Austin, Texas-based Arise Vascular has opened the Cardiovascular Surgery […]
Commercialized Products is Allowed to be Sold in Most of the Provinces in China Continue to Grow Sales of a Product Suite of Stroke Thrombectomy Devices HONG KONG, Aug. 31, 2021 /PRNewswire/ — Shanghai HeartCare Medical Technology Corporation Limited (“HeartCare Medical” or the “Company“, together with its subsidiaries, the “Group“, stock code: 6609), […]
Ghent, Belgium – 31 August 2021 – Sequana Medical NV (Euronext Brussels: SEQUA, the “Company”), an innovator in the treatment of diuretic-resistant fluid overload in liver disease, malignant ascites and heart failure, today announces that it has appointed Jackie Fielding, a former Vice President of Medtronic with more than 30 […]
ALLEN, Texas, Aug. 30, 2021 (GLOBE NEWSWIRE) — Atrion Corporation (NASDAQ: ATRI) today announced the election of Maria Sainz as a director, effective immediately. Ms. Sainz brings to our Board over 20 years of medical device and management experience from both Silicon Valley start-ups and large medical device companies. During […]
PARIS–(BUSINESS WIRE)–TISSIUM, a privately-owned medtech company developing biomorphic programmable polymers for tissue reconstruction, announced it has closed a Series C round of financing, raising €50 million from new and existing international investors. Cathay Health, affiliated to global investment firm Cathay Capital, led new investors and joined other institutional and individual backers […]
OAKLAND, Calif.–(BUSINESS WIRE)–Promaxo, Inc. (“Promaxo” or the “Company”), a medical imaging, robotics, and AI technology company, announced today the appointment of Paul Brathwaite, Ph.D. as Vice President of Robotics. “Paul’s expansive knowledge of medical device development and his collaborative leadership style are invaluable assets to Promaxo, as we enhance our […]
PRAIRIE VILLAGE, Kan., Aug. 31, 2021 /PRNewswire/ — Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and structural heart markets, today announced the hiring of Wendy Sawyer as Senior Vice President of Operations and Quality and Mimi Fitterer as Senior Director of Technology. Sawyer joins Artio with over 30 years […]
Humacyte raises $245M gross proceeds Combined company is expected to begin trading on the Nasdaq Global Select Market® under “HUMA” and “HUMAW” on August 27, 2021 Company well-positioned to deliver on promise of regenerative tissue HAV technology for initial indications in vascular trauma, AV access and peripheral arterial disease Combined […]
Dr. Killeen joins Renovacor from BioMarin where he led the discovery and development of AAV-based gene therapies for inherited cardiac diseases PHILADELPHIA, Aug. 25, 2021 (GLOBE NEWSWIRE) — Renovacor, Inc. (“Renovacor”), an early‑stage biotechnology company developing adeno-associated virus (AAV)‑based gene therapies for devastating cardiovascular and central nervous system diseases resulting […]
Oversubscribed round enables late-stage clinical development of lead candidate, a micro-RNA-132 inhibitor, in heart failure and further accelerates pipeline expansion HANOVER, Germany–(BUSINESS WIRE)–Cardior Pharmaceuticals, a clinical-stage biotech company developing non-coding RNA (ncRNA)-based therapeutics for patients with cardiac diseases, announced today the closing of a €64 million ($76 million) Series B […]
